Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.
about
Endothelial progenitor cells: what use for the cardiologist?Circulating endothelial progenitor cells as a predictor of response to cardiac resynchronization therapy: the missing piece of the puzzle?Circulating apoptotic progenitor cells in patients with congestive heart failure.Endothelial progenitor cells in cardiovascular diseases.Changes in the frequency and in vivo vessel-forming ability of rhesus monkey circulating endothelial colony-forming cells across the lifespan (birth to aged).Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome.Resident vascular progenitor cells--diverse origins, phenotype, and functionEndothelial progenitor cells in cardiovascular diseases: from biomarker to therapeutic agentEndothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.Circulating Endothelial Progenitor Cells and Clinical Outcome in Patients with Aortic StenosisEnhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair.Circulating endothelial progenitor cells in cardiovascular disorders.Endothelial progenitor cells: markers of vascular reparative capacity.From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells.Monocytes in heart failure: relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?Endothelial progenitor cells and endothelial vesicles - what is the significance for patients with chronic kidney disease?Mobilization of stem and progenitor cells in cardiovascular diseases.Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.Are endothelial progenitor cells a prognostic factor in patients with heart failure?BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure.Monocyte-derived and CD34+/KDR+ endothelial progenitor cells in heart failure.Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure.Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction.Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis.Aerobic training and angiogenesis activation in patients with stable chronic heart failure: a preliminary report.Testosterone deficiency in male heart failure patients and its effect on endothelial progenitor cells.
P2860
Q21198698-9E58752D-517D-4CF3-A12A-53D71CFCB819Q33357429-2D3AE42C-3FB1-4022-A79E-F90371F350E0Q33370283-EC973C2A-53A5-42FB-8D3F-988EFA5C8696Q34038864-9123BC9E-D109-4D7C-BED8-519009A8CF9BQ34248148-62E5928B-BCE8-4828-81E0-C2FB767716A2Q34410068-67C2D8D4-5DDC-466F-B1B3-483FEBD78BB8Q34625321-07475D7D-9DDC-42DF-8240-5178DF0FE56EQ35604291-FCCD4CF1-10B4-407C-A22A-BB22591D43D8Q35774189-44D76449-AD0B-45AC-9F2F-0570A32048CEQ35935375-8F84798E-B4FD-4891-8AA5-A2B0075BE3A5Q36121810-A514CBB0-8546-455C-AD29-9B2F4242DD67Q37269391-FB3AB533-750C-466C-9E8E-58B22BEABE1AQ37362743-FAC1F53C-C5E5-43E2-B016-593549BBFBE3Q37418551-86F5CCE6-1A0A-41C9-8C1B-3DCC17821EC4Q37608787-3BA6C9E3-09D9-488C-BC4C-0B4C38D4CB6FQ37679623-3E97348C-0A29-4E37-8514-9D29611E0A7EQ37905521-AEFED61D-3A05-4673-8E94-B49ABD7D4899Q37968218-A55F7E0C-BF67-41D0-B4DA-400CB2570215Q37980252-84BEADB5-FD50-4CEB-ACA0-82015C916ADEQ38225445-A6A27CDD-97E4-4A3B-9296-4C0291C2D295Q39626848-B2F61588-96EA-46E9-86C4-F77E44AEA5A0Q40090125-B77886C3-C3FF-4CAA-A82D-FCE6E6EBA14EQ41999187-CE12C16F-80F9-4F97-A415-4FA941E63DE6Q42703611-5CCE7477-7A38-42E4-8DBC-389DF506AEC0Q45976155-5B75A697-D0C0-4008-B017-35C49A890BC1Q46622856-236F491E-E7AB-4814-93EE-652D0036A991Q50929419-434311B6-95F7-42A7-B0AA-C58792135563
P2860
Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Circulating endothelial progen ...... with congestive heart failure.
@ast
Circulating endothelial progen ...... with congestive heart failure.
@en
type
label
Circulating endothelial progen ...... with congestive heart failure.
@ast
Circulating endothelial progen ...... with congestive heart failure.
@en
prefLabel
Circulating endothelial progen ...... with congestive heart failure.
@ast
Circulating endothelial progen ...... with congestive heart failure.
@en
P2093
P2860
P356
P1433
P1476
Circulating endothelial progen ...... with congestive heart failure.
@en
P2093
David Sheps
Dov Wexler
Emil Goldstein
Yoav Michowitz
P2860
P304
P356
10.1136/HRT.2006.102657
P407
P50
P577
2007-02-03T00:00:00Z